Evaluation of Cognitive Impairment in the Elderly Admitted to Nursing Homes
NCT ID: NCT05404152
Last Updated: 2022-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
390 participants
OBSERVATIONAL
2021-12-31
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Daily Cognition Training in Older Adults Without Cognitive Impairment
NCT05688163
Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects
NCT05640141
Home-based Cognitive Monitoring in MCI
NCT04350801
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
NCT01316562
Dementia in Migrants Living in Italy: Promoting a Diversity-sensitive Clinical Approach and Provision of Care
NCT06416137
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ederly
Elderly Admitted to Nursing homes
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elderly Admitted to Nursing homes
* From 60 years old
Exclusion Criteria
* Existence of doubts about the presence of IC
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MARIA ELENA MOSQUERA LOSADA
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MARIA ELENA MOSQUERA LOSADA, MSc in Nursing
Role: PRINCIPAL_INVESTIGATOR
Universidad de Murcia
ANTONIA GOMEZ-CONESA, PhD, PT
Role: STUDY_DIRECTOR
Universidad de Murcia
RAMON GONZALEZ CABANACH, PhD
Role: STUDY_DIRECTOR
Universidade da Coruña
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UMurcia
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIE/UM22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.